Browsing by Subject "A61K 48/00"

Now showing items 1-5 of 5

    • Cardiac myofibiril induction 
      Lemanski, Larry F.; Arms, Ashley; Kochegarov, Andrei (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2019-09-17)
      Methods and products for altering or promoting the development of heart tissue are disclosed. The methods include the use of nucleic acids of cardiogenic inducing factor for treating a subject having heart disease.
    • Compounds and methods for the treatment of cancer 
      Zingaro, Ralph A.; Zingaro, Ralph A. (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2012-07-17)
      The present invention provides organic arsenicals which may be used to treat numerous human tumor cell lines, both of solid and hematological origin, as well as against malignant blood cells from patients with leukemia.
    • Melatonin-based treatment and diagnosis of bile duct disease 
      Alpini, Gianfranco; Demorrow, Sharon; Glaser, Shannon (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2016-10-18)
      Methods and composition for a melatonin signaling modulator-based diagnosis and therapy are described. For example, in certain aspects methods for administering an anti-tumor therapy using a melatonin signaling modulator ...
    • Vaccine vectors and methods of enhancing immune responses 
      Berghman, Luc; Bottje, Walter; Hargis, Billy; Layton, Sherryll (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2015-02-17)
      Provided herein are vaccine vectors including an antigenic polypeptide and an HMGB1 polypeptide present on the surface of the vaccine vector. Compositions comprising the vaccine vectors are also provided and include a ...
    • Vaccine vectors and methods of enhancing immune responses 
      Berghman, Luc; Bottje, Walter; Hargis, Billy; Layton, Sherryll (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2018-03-13)
      Provided herein are vaccine vectors including an antigenic polypeptide and an HMGB1 polypeptide present on the surface of the vaccine vector. Compositions comprising the vaccine vectors are also provided and include a ...